- Home
- ELVN vs PLAB Comparison
ELVN vs PLAB Comparison
Compare ELVN & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PLAB
- Stock Information
- Founded
- ELVN 2016
- PLAB 1969
- Country
- ELVN United States
- PLAB United States
- Employees
- ELVN N/A
- PLAB N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PLAB Semiconductors
- Sector
- ELVN Health Care
- PLAB Technology
- Exchange
- ELVN Nasdaq
- PLAB Nasdaq
- Market Cap
- ELVN 1.2B
- PLAB 1.2B
- IPO Year
- ELVN 2020
- PLAB 1987
- Fundamental
- Price
- ELVN $19.72
- PLAB $22.54
- Analyst Decision
- ELVN Strong Buy
- PLAB Strong Buy
- Analyst Count
- ELVN 5
- PLAB 2
- Target Price
- ELVN $41.20
- PLAB $31.00
- AVG Volume (30 Days)
- ELVN 421.4K
- PLAB 698.0K
- Earning Date
- ELVN 08-13-2025
- PLAB 08-27-2025
- Dividend Yield
- ELVN N/A
- PLAB N/A
- EPS Growth
- ELVN N/A
- PLAB N/A
- EPS
- ELVN N/A
- PLAB 1.77
- Revenue
- ELVN N/A
- PLAB $856,152,000.00
- Revenue This Year
- ELVN N/A
- PLAB N/A
- Revenue Next Year
- ELVN $25.00
- PLAB $5.06
- P/E Ratio
- ELVN N/A
- PLAB $12.81
- Revenue Growth
- ELVN N/A
- PLAB N/A
- 52 Week Low
- ELVN $13.30
- PLAB $16.46
- 52 Week High
- ELVN $30.03
- PLAB $31.60
- Technical
- Relative Strength Index (RSI)
- ELVN 47.40
- PLAB 56.53
- Support Level
- ELVN $18.80
- PLAB $21.86
- Resistance Level
- ELVN $21.30
- PLAB $22.87
- Average True Range (ATR)
- ELVN 0.99
- PLAB 0.75
- MACD
- ELVN -0.06
- PLAB -0.06
- Stochastic Oscillator
- ELVN 36.80
- PLAB 31.16
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PLAB Photronics Inc.
Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.